VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

41 hedge funds and large institutions have $14.1M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
11
Closed
11
Calls
$9K
Puts
$3K
Net Calls
+$6K
Net Calls Change
+$2K

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$235K
2
B
2
Bailard
California
$67.3K
3
HF
3
HRT Financial
New York
$24K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$23.7K
5
BlackRock
5
BlackRock
New York
$649K

Top Sellers

1
RCMNY
1
Rubric Capital Management (New York)
New York
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
GGHC
3
Gilder Gagnon Howe & Co
New York
$0
4
JRP
4
Jasper Ridge Partners
California
$0
5
Millennium Management
5
Millennium Management
New York
$77K
Name Market Value Shares Shares
Change 		Shares
Change %
TWD
51
True Wealth Design
Ohio
– – -200 Closed
BWP
52
Baldwin Wealth Partners
Massachusetts
– – -47 Closed
Simplex Trading
53
Simplex Trading
Illinois
– – – –
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3